Back to search

Peptide record

TPDB92295

Figanin 2BN Antibacterial Anticancer standard
27 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB92295
Figanin 2BN
Antibacterial Anticancer
Anti-infective peptides Cancer-related peptides
Peptipedia CancerPPD 2.0 dbACP
standard
No
A 27-aa standard natural multi-activity (Antibacterial and Anticancer) peptide sequence curated from Peptipedia, CancerPPD 2.0, and dbACP, with an available 3D structural model.
C-terminal: Amidation
Sequence
FLGVALKLGKVLGKALLPLASSLLHSQ-NH2
Physicochemical Analysis
C131H225N33O32
RNDCEIMTWY
L
2774.43
10.84
4
0
15
+3
-1.16
1.007
162.59
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
4
Residue Composition
number
3
A
0
R
0
N
0
D
0
C
0
E
1
Q
3
G
1
H
0
I
9
L
3
K
0
M
1
F
1
P
3
S
0
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 3 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 1 G: 3 H: 1 I: 0 L: 9 K: 3 M: 0 F: 1 P: 1 S: 3 T: 0 W: 0 Y: 0 V: 2
Chemical Descriptors
27
C131H225N33O32
2774.43
10.84
+3
-1.16
1.007
Amidation
L
Linear
Free
Antimicrobial and Antitumor
Giant Gladiator Treefrog (Boana boans)
Evidence Records 3 records
Evidence 1 Activity

Activity

LC50
LC50 = 6.7 uM
Anticancer
6.7 µM

Target

Lung Cancer
A-549
Lung

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

LC50
LC50 = 8.1 uM
Anticancer
8.1 µM

Target

Breast Cancer
MDA-MB-231
Breast

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2023
Evidence 3 Activity

Activity

LC50
LC50 = 14.1 uM
Anticancer
14.1 µM

Target

Colon Cancer
HT-29
Colon

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2023